Pembelian
ASXC FDA approval sell the leap options
ASXC has FDA approval for the surgical device granted this month.
ASXC has adequate cash for two year burn as sales are ramped up.
Sell the ASXC Jan 2023 leap options and the raw cost is $2 per share. Stock is as of today $3.80 range.
Invest the cash in GGN and trade GGN monthly into the dividend ex-date.
own the stock for nearly free at any cost in 21 months.
good product
small cap with adequate share count and volume.
reasonable speculation
see the links below...
all the best.
ASXC has adequate cash for two year burn as sales are ramped up.
Sell the ASXC Jan 2023 leap options and the raw cost is $2 per share. Stock is as of today $3.80 range.
Invest the cash in GGN and trade GGN monthly into the dividend ex-date.
own the stock for nearly free at any cost in 21 months.
good product
small cap with adequate share count and volume.
reasonable speculation
see the links below...
all the best.
Catatan
GGN up today with 2 weeks to monthly distribution dates. Sold mine today...
not an April Fools day joke...
Publikasi terkait
Pernyataan Penyangkalan
Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.
Publikasi terkait
Pernyataan Penyangkalan
Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.